冠状动脉粥样硬化斑块消退:JACC 最新综述
斑块进展先于心血管事件,多项纵向研究评估治疗对斑块特征的影响以证明消退;若斑块消退与事件减少关联,未来可能直接影像指导治疗决策。
要点
- 斑块进展先于心血管事件,消退与高风险特征改善是治疗目标。
- 侵入与非侵入冠脉影像可纵向评估斑块体积和成分变化。
- 若斑块消退能预测事件减少,影像可能指导一级和二级预防决策。
核心结论
- 斑块消退和高风险特征改善有望减少心血管事件,但需结局数据验证。
主要发现
- 斑块进展先于心血管事件,多种治疗可纵向评估斑块特征变化。
临床怎么用
- 目前治疗决策仍基于人群风险评分启动一级预防和低密度脂蛋白胆固醇滴定二级预防。
- 若结局数据证实斑块消退减少事件,未来可能直接影像斑块治疗反应指导管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the last 3 decades there have been substantial improvements in treatments aimed at reducing cardiovascular (CV) events. As these treatments have been developed, there have been parallel improvements in coronary imaging modalities that can assess plaque volumes and composition, using both invasive and noninvasive techniques. Plaque progression can be seen to precede CV events, and therefore, many studies have longitudinally assessed changes in plaque characteristics in response to various treatments, aiming to demonstrate plaque regression and improvements in high-risk features, with the rationale being that this will reduce CV events. In the past, decisions surrounding treatments for atherosclerosis have been informed by population-based risk scores for initiation in primary prevention and low-density lipoprotein cholesterol levels for titration in secondary prevention. If outcome data linking plaque regression to reduced CV events emerge, it may become possible to directly image plaque treatment response to guide management decisions.
引用
- Dawson LP, Lum M, Nerleker N, et al. Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 34991791. doi:10.1016/j.jacc.2021.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。